Vaxxinity Inc - Class A

OTCPK:VAXX (USA)   Class A
$ 0.00 +0.0001 (+25%) 11:09 PM EST
At Loss
Market Cap:
$ 51.00K
Enterprise V:
$ -15.19M
Volume:
1.40K
Avg Vol (2M):
26.16K
Trade In:
Volume:
1.40K
At Loss
Avg Vol (2M):
26.16K

Business Description

Vaxxinity Inc
NAICS : 541714 SIC : 2834
ISIN : US92244V1044

Share Class Description:

VAXX: Class A
Description
Vaxxinity Inc is a biotechnology company committed to democratizing healthcare across the globe. The company is pioneering a new class of synthetic, peptide-based active immunotherapy medicines aimed at disrupting the existing treatment paradigm for chronic disease, increasingly dominated by monoclonal antibodies, which suffer from prohibitive costs and cumbersome administration. The company's proprietary technology platform has enabled the innovation of novel pipeline candidates designed to bring the efficiency of vaccines to the treatment of chronic diseases, including Alzheimer's, Parkinson's, migraine, and hypercholesterolemia.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 2
Equity-to-Asset 0.3
Debt-to-Equity 1.13
Debt-to-EBITDA -0.28
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -11.9
3-Year EPS without NRI Growth Rate -18.9
3-Year FCF Growth Rate -17.4

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 73.56
9-Day RSI 50.78
14-Day RSI 47.35
6-1 Month Momentum % -99.88
12-1 Month Momentum % -99.97

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.89
Quick Ratio 1.89
Cash Ratio 1.73

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.5
Shareholder Yield % -4010.32

Profitability Rank

Name Current Vs Industry Vs History
ROE % -157.77
ROA % -77.97
ROIC % -393.23
ROC (Joel Greenblatt) % -480.86
ROCE % -114.9

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT 0.27
EV-to-EBITDA 0.28
EV-to-FCF 0.26
Price-to-Net-Current-Asset-Value 0.03
Earnings Yield (Greenblatt) % 370.37
FCF Yield % -113805.88

Financials (Next Earnings Date:2024-12-27 Est.)

VAXX's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:VAXX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Vaxxinity Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.45
Beta 0.41
Volatility % 971.81
14-Day RSI 47.35
14-Day ATR ($) 0.037342
20-Day SMA ($) 0.000175
12-1 Month Momentum % -99.97
52-Week Range ($) 0.0001 - 1.1
Shares Outstanding (Mil) 126.78

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Vaxxinity Inc Filings

Filing Date Document Date Form
No Filing Data

Vaxxinity Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Vaxxinity Inc Frequently Asked Questions

What is Vaxxinity Inc(VAXX)'s stock price today?
The current price of VAXX is $0.00. The 52 week high of VAXX is $1.10 and 52 week low is $0.00.
When is next earnings date of Vaxxinity Inc(VAXX)?
The next earnings date of Vaxxinity Inc(VAXX) is 2024-12-27 Est..
Does Vaxxinity Inc(VAXX) pay dividends? If so, how much?
Vaxxinity Inc(VAXX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1